Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer

Clinical trial NCT03251365 · UNKNOWN

Trial details

NCT number: NCT03251365
Sponsor: Hospital General de Ciudad Real
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Resectable Pancreatic Adenocarcinoma

Start date: 2017-07-27
Primary completion: 2020-12-31
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.